Geospatial Analysis of Statin Adherence Using Pharmacy Claims Data in the State of Michigan

被引:13
|
作者
Erickson, Steven R. [1 ]
Tony, Yuan-Nung [2 ]
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Diplomat Pharm, Flint, MI USA
来源
关键词
CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; GEOGRAPHIC-VARIATION; MEDICATION ADHERENCE; MULTILEVEL ANALYSIS; PARKINSONS-DISEASE; NEIGHBORHOOD; OUTCOMES; NONADHERENCE;
D O I
10.18553/jmcp.2014.20.12.1208
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Research has demonstrated that variation in availability and utilization of health care resources exist on a range of scales, from regions of the United States, hospital referral regions, ZIP codes, and census tracts. Limited research using spatial analyses has found that variation in medication adherence exists across census tracts. Using spatial analysis, researchers may be able to effectively analyze geographically dispersed data to determine whether factors such as soclodemographics, local shared beliefs and attitudes, barriers to access such as availability of prescribers or pharmacies, or others are associated with variations in medication adherence in a defined geographic area. OBJECTIVES: To (a) demonstrate that medication adherence may be mapped across an entire state using medication possession ratios and (b) determine whether a geographic pattern of adherence to statins could be identified at the ZIP code level for members of a statewide insurer. METHODS: This study utilized pharmacy claims data from a statewide Insurer. Insured statin users were aged >30 years, had at least 1 statin prescription, and were continuously enrolled for the observation year. Patient medication possession ratios (MPR) were derived, which were then aggregated as a mean MPR for each ZIP code. ZIP codes were categorized as higher (MPR>0.80) or lower (MPR<0.80) adherence and mapped using Arc GIS, a platform for designing and managing solutions through the application of geographic knowledge. Analysis included a determination of whether the MPRs of higher and lower adherence ZIP codes were significantly different. Hot spot analysis was conducted to identify clustering of higher, midrange, and lower adherent ZIP codes using the GetisORD GI* Statistic. This test provides z-scores and P values to indicate where features with either high or low values cluster spatially. MPRs for these 3 categories were compared using one-way analysis of variance (ANOVA). RESULTS: Of 1,154 Michigan ZIP codes, 907 were represented by 212,783 insured statin users. The mean statin MPR by ZIP code was 0.79 +/- 0.4. The mean MPR for higher adherent ZIP codes was 0.83 +/- 0.03 and 0.76 +/- 0.03 for lower adherent ZIP codes (P<0.001). Significant clustering of ZIP codes by adherence levels was evident from the hot spot analysis. The mean MPR was 0.84 +/- 0.04 for high adherence areas, 0.79 +/- 0.03 for midrange areas, and 0.74 +/- 0.04 for lower adherent areas (overall P<0.001). CONCLUSIONS: Significant variations in adherence exist across ZIP codes at a state level. Future research is needed to determine locally relevant factors associated with this finding, which may be used to derive locally meaningful interventions. Copyright(C)2014, Academy of Managed Care Pharmacy. All rights reserved.
引用
收藏
页码:1208 / 1215
页数:8
相关论文
共 50 条
  • [41] Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy
    Torres-Robles, Andrea
    Wiecek, Elyssa
    Cutler, Rachelle
    Drake, Barry
    Benrimoj, Shalom I.
    Fernandez-Llimos, Fernando
    Garcia-Cardenas, Victoria
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [42] The predictive validity of different adherence measures using administrative claims data
    Karve, S. J.
    Martin, B. C.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A85 - A85
  • [43] Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature
    Sattler, Elisabeth Lilian Pia
    Lee, Jung Sun
    Perri, Matthew, III
    [J]. DRUGS & AGING, 2013, 30 (06) : 383 - 399
  • [44] Comparison of a new three-item self-reported measure of adherence to medication with pharmacy claims data
    Lauffenburger, Julie C.
    Fontanet, Constance P.
    Isaac, Thomas
    Gopalakrishnan, Chandrasekar
    Sequist, Thomas D.
    Gagne, Joshua J.
    Jackevicius, Cynthia A.
    Fischer, Michael A.
    Solomon, Daniel H.
    Choudhry, Niteesh K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 195 - 196
  • [45] Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature
    Elisabeth Lilian Pia Sattler
    Jung Sun Lee
    Matthew Perri
    [J]. Drugs & Aging, 2013, 30 : 383 - 399
  • [46] ASSESSING DEMENTIA: AN ANALYSIS OF COGNITIVE SCORES, PHARMACY COSTS, AND MEDICATION ADHERENCE USING UNSTRUCTURED AND STRUCTURED DATA
    Verma, V.
    Rastogi, M.
    Chawla, S.
    Nayyar, A.
    Gaur, A.
    Daral, S.
    Kukreja, I
    Roy, A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S360 - S360
  • [47] Primary non-adherence to biologics and immunomodulatory therapies for rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis using linked EHR and pharmacy claims data
    Curtis, Jeffrey
    Su, Yujie
    Clinton, Cassie
    Stewart, Patrick
    England, Bryant
    Xie, Fenglong
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 530 - 531
  • [48] Primary Non-adherence to Biologics and Immunomodulatory Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis Using Linked EHR and Pharmacy Claims Data
    Curtis, Jeffrey
    Su, Yujie
    Clinton, Cassie
    Stewart, Patrick
    England, Bryant
    Buekelman, Tim
    Xie, Fenglong
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4360 - 4362
  • [49] Validity of the Adherence Estimator in the Prediction of 9-Month Persistence With Medications Prescribed for Chronic Diseases: A Prospective Analysis of Data From Pharmacy Claims
    McHorney, Colleen A.
    Spain, C. Victor
    Alexander, Charles M.
    Simmons, Jeffrey
    [J]. CLINICAL THERAPEUTICS, 2009, 31 (11) : 2584 - 2607
  • [50] Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
    Karve, Sudeep
    Cleves, Mario A.
    Helm, Mark
    Hudson, Teresa J.
    West, Donna S.
    Martin, Bradley C.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (09) : 2303 - 2310